Neurelis Stock
Neurelis is a neuroscience-based pharmaceutical company focused on developing and commercializing life-changing therapies for people living with epilepsy and other neurological disorders. Its lead product, VALTOCO® (diazepam nasal spray), is a unique, FDA-approved treatment for acute seizure clusters.
For more Neurelis stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Craig Chambliss Co-Founder, CEO, and President |
| Jenny Alonzo General Counsel and Chief Compliance Officer |
| Brittany Bradrick COO and CFO |
| Chuck Dewildt Chief Commercial Officer |
| Stuart Madden, Ph.D. Chief Scientific Officer |
| Adrian Rabinowicz, M.D. Chief Medical Officer |
